VIRAL HEPATITIS

Clinical trials for VIRAL HEPATITIS explained in plain language.

Never miss a new study

Get alerted when new VIRAL HEPATITIS trials appear

Sign up with your email to follow new studies for VIRAL HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3 Completed 3

Hepatitis b drug showdown: which is safer for kidneys?

Disease control Recruiting now

This study compares two antiviral drugs, tenofovir alafenamide (TAF) and entecavir, in 140 adults with chronic hepatitis B. The goal is to see which one controls the virus better and causes fewer kidney problems. Participants take one pill daily for about a year.

Matched conditions: VIRAL HEPATITIS

Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

VIRAL HEPATITIS

Get alerted when new VIRAL HEPATITIS trials appear

Hepatitis b drug showdown: which is safer for kidneys?